tiprankstipranks
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
KYMR
Kymera Therapeutics
RESEARCH TOOLSreports

Kymera Therapeutics (KYMR) Balance Sheet

423 Followers

Kymera Therapeutics Balance Sheet

Kymera Therapeutics's total assets for Q4 2025 were $1.74B, an increase of 58.14% from the previous quarter. KYMR total liabilities were $163.15M for the fiscal quarter, a 4.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 1.74B$ 978.03M$ 575.76M$ 603.13M$ 605.90M
Total Liabilities
$ 163.15M$ 142.42M$ 180.79M$ 112.98M$ 146.27M
Total Equity Gross Minority
$ 1.58B$ 835.62M$ 394.97M$ 490.15M$ 459.64M
Other Metrics
Currency in USD

Kymera Therapeutics Debt to Assets